7076 - 7100 of 8826 Results
Title
Year
-
OPENTitle: No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 141Issue #: 3Start Page: e16End Page: e16Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awx378Best OA location URL: https://academic.oup.com/brain/article-pdf/141/3/e16/25046297/awx378.pdfCitation Count: 13
-
OPENTitle: Cognitive processes that indirectly affect olfactory dysfunction in Parkinson's diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 1Issue #:Start Page: 13End Page: 20Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.prdoa.2019.07.003Best OA location URL: https://doi.org/10.1016/j.prdoa.2019.07.003Citation Count: 7
-
OPENTitle: The glucocerebrosidase mutations and uric acid levels in Parkinson’s disease: A 3-years investigation of a potential biomarker”Journal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 8Issue #:Start Page: 100177End Page: 100177Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100177Best OA location URL: https://doi.org/10.1016/j.prdoa.2022.100177Citation Count: 3
- Increased dopaminergic function in the thalamus is associated with excessive daytime sleepiness2017OPENTitle: Increased dopaminergic function in the thalamus is associated with excessive daytime sleepinessJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 43Issue #:Start Page: 25End Page: 30Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.sleep.2017.11.1137Citation Count: 13
-
OPENTitle: Hydrop enables droplet-based single-cell ATAC-seq and single-cell RNA-seq using dissolvable hydrogel beadsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.7554/elife.73971Best OA location URL: https://doi.org/10.7554/elife.73971Citation Count: 68
-
OPENTitle: RTP801 interacts with the tRNA ligase complex and dysregulates its RNA ligase activity in Alzheimer’s diseaseJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 52Issue #: 18Start Page: 11158End Page: 11176Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/nar/gkae776Best OA location URL: https://doi.org/10.1093/nar/gkae776Citation Count: 4
- GBA 1 rs3115534 Is Associated with REM Sleep Behavior Disorder in Parkinson's Disease in Nigerians2024OPENTitle: GBA 1 rs3115534 Is Associated with REM Sleep Behavior Disorder in Parkinson's Disease in NigeriansJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 4Start Page: 728End Page: 733Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29753Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29753Citation Count: 8
- Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease2020OPENTitle: Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 7Issue #: 4Start Page: 449End Page: 461Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/acn3.51022Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51022Citation Count: 83
-
OPENTitle: Dopamine transporter imaging predicts clinically‐defined α‐synucleinopathy in REM sleep behavior disorderJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 1Start Page: 201End Page: 212Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/acn3.51269Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51269Citation Count: 61
-
OPENTitle: Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patientsJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 7Issue #: 10Start Page: 1816End Page: 1830Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/acn3.51164Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51164Citation Count: 40
-
OPENTitle: α‐synuclein genetic variability: A biomarker for dementia in Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 79Issue #: 6Start Page: 991End Page: 999Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.24664Best OA location URL: http://hdl.handle.net/2027.42/137619Citation Count: 98
-
OPENTitle: Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 88Issue #: 3Start Page: 574End Page: 587Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25811Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.25811Citation Count: 102
- Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's Disease2024OPENTitle: Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 95Issue #: 6Start Page: 1162End Page: 1172Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26923Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26923Citation Count: 19
-
OPENTitle: Sex Disparities in Autonomic Symptom Treatment in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 6Start Page: 718End Page: 719Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12997Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12997Citation Count: 7
-
OPENTitle: Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 919End Page: 927Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26170Best OA location URL: http://doi.org/10.1002/mds.26170Citation Count: 303
-
RESTRICTEDTitle: Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 9Start Page: 1229End Page: 1236Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26251Best OA location URL: http://doi.org/10.1002/mds.26251Citation Count: 115
- Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progression2016OPENTitle: Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progressionJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 10Start Page: 1535End Page: 1542Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26754Citation Count: 149
-
OPENTitle: Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative CohortJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 5Start Page: 771End Page: 782Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27361Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27361Citation Count: 203
- 123I‐FP‐CIT SPECT [(123) I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α‐synuclein Parkinson's disease cohort versus Parkinson's disease2018RESTRICTEDTitle: 123I‐FP‐CIT SPECT [(123) I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α‐synuclein Parkinson's disease cohort versus Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 11Start Page: 1734End Page: 1739Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27451Citation Count: 12
- Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's disease2019OPENTitle: Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 9Start Page: 1354End Page: 1364Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27806Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27806Citation Count: 139
-
OPENTitle: Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross‐Sectional StudyJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 833End Page: 844Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27989Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27989Citation Count: 78
- Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression2020OPENTitle: Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 1999End Page: 2008Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28206Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28206Citation Count: 194
-
OPENTitle: Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1972End Page: 1978Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28608Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28608Citation Count: 39
-
OPENTitle: CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative studyJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 131Issue #: 6Start Page: 935End Page: 949Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-016-1552-2Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/40503Citation Count: 216
- Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)2020RESTRICTEDTitle: Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4418Citation Count: 1